Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Advent Life Sciences
Biotech
Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders
Alchemab CEO suddenly resigns. Infant biotech Civeta builds out scientific leadership. Rajangam jumps from Nkarta to Senti Bio.
Max Bayer
May 27, 2022 9:30am
Advent raises $215M to nurture another troop of biotechs
Feb 18, 2021 2:00am
Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic
May 19, 2017 3:13am
Pfizer, Celgene-backed upstart Arrakis hopes to mine RNA spice
Feb 27, 2017 7:00am
